The sensitivity and specificity of recombinant open reading frame 5 products used in the Western blotting assay for confirmation of porcine reproductive and respiratory syndrome virus (PRRSV) serologic status were evaluated. The recombinant antigen-based assays were specifically compared with a commercial enzymelinked immunosorbent assay (ELISA) for PRRSV antibodies using 1) PRRSV antibody-negative reference sera (n ϭ 30), 2) naturally infected pig sera (n ϭ 40), 3) sequential sera obtained from 24 experimentally infected pigs, and 4) sera submitted to 3 state diagnostic laboratories (n ϭ 200). The recombinant antigen assay yielded an average increased sensitivity of 10% over the commercial PRRSV ELISA. The negative controls (group 1 sera) showed no difference between the 2 assays. This comparison confirmed that the recombinant antigenspecific assay was more sensitive than the commercial ELISA and is well suited for routine confirmation of the presence of PRRSV antibodies.
Porcine reproductive and respiratory syndrome (PRRS) was first recognized in swine herds in the United States in 1987. 8 Later, the syndrome was reported in Europe, Asia, and other areas of the world. 7, 19, 22 The disease is characterized by severe reproductive failure in breeding age swine, respiratory disease in young pigs, and increased preweaning mortality in suckling pigs. PRRS is presently considered to be the most serious infectious disease of domestic swine herds. 1, 20 The causative agent, PRRS virus (PRRSV), has been isolated. 3, 5, 23 Based on the size and morphology of the virion, viral genome organization, and the mode of replication strategy, the PRRSV has been placed in the genus Arterivirus. 4, 16 Other similar viruses of this group are lactate dehydrogenase elevating virus of mice, equine arteritis virus, and simian hemorrhagic fever virus. 7, 19 The arterivirus group shares the genome organization and expression strategy of the coronaviruses. On this basis, the International Committee on Taxonomy of Viruses recently established a new order, Nidovirales, to contain the 2 families. 6, 11 In infected cells, the approximately 15 15, 22, 25, 26 All of these tests employ native viral antigens, which are produced in a tissue culture system. Among these tests, the ELISA is used routinely for PRRSV antibody detection. 7 However, an important issue associated with PRRSV whole virus antigen preparation is that diagnostically relevant antigens may be not available in sufficient quantities to detect all infected animals. For example, a high molar ratio of ORF 7 and 6 proteins, relative to ORF 4 and 5 proteins, is found in the virion. 12, 18 Antibodies to ORF 5 protein appear to be major serologic markers in PRRSV-infected pigs. This finding is based on the detection of antibodies by Western blotting (WB) over a period of 150 days in infected animals (unpublished data). Therefore, because of the absence or under representation of ORF 4 and 5 antigens, the whole-virus ELISA may give an underestimation of the antibody directed against these antigens, which may then lead to false-negative results. In this study, the sensitivity and specificity of recombinant ORF 5 used in a WB assay for the confirmation of PRRSV antibodies were evaluated. In addition, the recombinant assays were compared with a commercial ELISA a for PRRSV antibody detection.
Materials and methods
Serum samples. Four groups of pig sera were included in this study. Group 1 consisted of 30 PRRSV-negative serum samples. These sera were collected from farms known to have a history of PRRSV-free status. Their status had also been confirmed by an IFA test 25 and the commercial ELISA. a These sera were used as negative controls. Group 2 consisted of 40 sera from pigs previously identified as infected with PRRSV. These sera were collected from farms with acute outbreaks of PRRS and had been confirmed by the PRRSV commercial ELISA kit. Group 3 consisted of sera obtained from experimentally infected pigs, 12 boars (subgroup A) and 12 gilts (subgroup B). In subgroup A, 5-6-month-old specific-pathogen-free animals were intranasally inoculated with 10 TCID 50 /2 ml of PRRSV 12068-96 strain, which was isolated from a farm (Syracuse, NE) with an acute outbreak of PRRSV-induced reproductive failure. 2, 8 Samples of serum were collected on days 0, 30, 45, 58, 71, 85, 92, 106, 113, 127, 148, 155, 169, 233, 248, 267, 297, 318, 343, 365, and 409 postinfection (PI). In subgroup B, the uninfected animals were intranasally exposed to 5 ϫ 10 5 PRRSV/5 ml NADC-8 strain, and blood was collected on days 0, 14, 26, 56, and 84 PI. Group 4 consisted of 200 swine sera submitted to 3 midwestern USA animal disease diagnostic laboratories and correspond to different cases that included sera serologically positive and negative for PRRSV.
Bacterial strain and plasmid. For the expression of the recombinant PRRSV, the prokaryotic plasmid pGex2T and an Escherichia coli JM105 host cell were used. b The procedures for induced expression and preparation of bacterial lysates for gel analysis and partial purification of recombinant proteins have been previously described. 10 Virus, cell line, and gene constructions. The PRRSV vaccine strain c was grown in the MARC-145 cell line. 9 This cell line is highly permissive to PRRSV and produces a high yield of infectious virus. To extract viral RNA, supernatant from infected MARC-145 cell lines was used. The viral RNA were used as a template and subjected to reverse transcription polymerase chain reaction (PCR) in an automated DNA thermal cycler. The DNA specifying ORFs 2-7 of the vaccine strain c has been sequenced, 24 and the entire ORF 5 was amplified through PCR techniques. The amplified PCR products were inserted into the pGex2T expression vector, resulting in the pGex2T-ORF5. In this construct, the correct translational frame required for expression of glutathione-stransferase (GST) fusion protein was confirmed by sequence analysis.
Western blotting. WB was performed essentially as previously described. 21 Following separation of the proteins by sodium dodecyl sulfate polyacrylamide gel electrophoresis, the proteins were blotted for 2 hours onto a prewetted transfer membrane d under a constant current of 200 mA. The blots were then blocked with 5% nonfat milk in Tris-buffered saline (10 mM Tris-HCl, pH 7.4, 150 mM NaCl) at room temperature for 1 hour. After blocking, the membranes were incubated overnight at 4 C with 1:50 dilution of serum samples. The protein bands were visualized by using the diaminobenzidine detection system. 10
Results
Recognition of recombinant antigen by sera from groups 1 and 2. The specific reactivity of the recombinant ORF 5 antigen was determined by WB assay using negative (group 1) and positive (group 2) reference sera. A prominent band at 42 kD was seen in WB of group 2 sera but not of group 1 sera. Figure 1 represents the results of a typical WB of groups 1 and 2 sera, showing their ability to specifically recognize the recombinant PRRSV ORF 5 protein. To confirm the absence of cross-reactivity with the GST moiety in group 2 sera, all sera were tested against purified GST. None of the group 2 sera reacted with the GST moiety of the fusion protein ( Fig. 1) raised in a guinea pig against purified GST recognized the 26-kD GST band in the GST blot. These data indicated that the expressed recombinant protein had the expected configuration and overall antigenicity of native PRRSV and that it is specifically recognized by all group 2 pig sera.
Recognition of recombinant antigens by group 3 sera and the comparison of their sensitivity with that of the ELISA kit. After infection, 20 sequential serum samples were collected from each subgroup A animal throughout the period of 409 days PI, and 4 sequential samples were collected from subgroup B animals. These samples were tested for antibodies to PRRSV by recombinant WB and the ELISA. To simplify the reporting of results, only 10 (days 58, 92, 127, 148, 169, 248, 267, 297, 318, 409) of the 20 sequential samples for subgroup A are presented in Table 1 . Antibodies to recombinant ORF 5 were demonstrated in all 12 infected boars throughout the 58-409 days PI (Table 1 ). In contrast, only 6 of 12 infected boars had antibodies consistently detected by the ELISA throughout the same period. The rest of the sera, from 148 days PI to 409 days PI, gave at least 1 negative result by ELISA. In some cases, the animal became permanently seronegative by ELISA (boars 280, 300, 344; Table 1 ). In other cases, the ELISA reactivity of the animal fluctuated between positive and negative (boars 283, 287; Table 1 ). However, there was complete correlation of results between the 2 tests from 30 days PI to 127 days PI (Table 1; Fig. 2 ). In subgroup B animals, both the ELISA and the recombinant ORF 5 test detected antibodies in gilts between 14 and 84 days PI. Combining the results from subgroups A and B supports the assumption that ORF 5 product is an immunodominant protein in the course of PRRSV infection, and the antibodies produced persist for a long time after infection, being detectable even beyond the detection span of the commercial ELISA.
Recognition of recombinant antigen by group 4 sera and the comparison of their sensitivity with that of the ELISA kit. Given the increased sensitivity of the WB over the ELISA in the group 3 sera, it is speculated that the recombinant ORF 5 product used in the WB should make it possible to detect antibody in field samples that were nonreactive in the ELISA. For this purpose, 200 field sera collected from 3 state diagnostic laboratories were analyzed. These samples were originally submitted for PRRSV antibody testing. Of the 200 samples, the ELISA detected 29% as positive and the WB detected 39% as positive. The results also suggest that the ORF 5 WB was more sensitive than the ELISA for the detection of antibody to PRRSV.
Discussion
The recombinant WB was more sensitive than the commercial ELISA kit in detecting PRRSV antigen. The failure of the ELISA to detect antibodies in some of the infected animals could be explained by a lack or underrepresentation of ORF 5 product in the antigen preparation. However, the recombinant assay format increases the density/frequency of diagnostically relevant epitopes compared with the viral lysate, resulting in increased sensitivity. Furthermore, well-defined, uniform, and reproducible recombinant proteins have distinct quality control advantages over tissue culturederived virus proteins when used as an antigen in serodiagnostic assays. Thus, the recombinant ORF 5 WB should be considered a more sensitive test for the detection of antibody to PRRSV.
The antibodies measured by these 2 tests may not be the same. The ELISA most likely detects ORF 7 and 6 epitopes, which are the most abundant antigens in the virion, whereas the WB only detects a specific antibody to ORF 5 product. Two research studies have demonstrated that the ORF 5 product is underpresented in virus preparations grown in tissue culture 12, 18 making the ELISA inherently less sensitive than the WB assay. As previously reported, 12 the antibodies to recombinant ORF 5 product could be demonstrated as early as 6 days PI, whereas antibody to ORFs 6 and 7 could only be detected by the end of the week 2 PI. Those data and the data reported here indicate that the antibodies to the ORF 5 product appear first during PRRSV infection and persist for a long time as compared with ORF 6 and ORF 7 products. In group 4 sera, the WB yielded an increased sensitivity of 10% over the commercial ELISA. These additional animals with detectable antibodies by WB may be in early (6-13 days PI) or late staged of infection.
Lack of sufficient ORF 5 and other ORF proteins in virus particles was further investigated by immunizing animals with bacterially expressed purified recombinant ORF 4 and ORF 5 or DNA-based constructs (unpublished data). Very low numbers or no antibodies to ORF 4 or ORF 5 products were detected in the ELISA system. In contrast, the antibodies to ORF 4 and ORF 5 products were readily detected in their respective recombinant WB (data not shown). The ability of the ORF 5 product from this U.S. strain to detect antibodies induced by European strains has not been investigated and remains to be studied further. One drawback of the WB assay is that it may be inconvenient to screen large numbers of samples for epidemiologic studies. However, this WB is sensitive and specific al-ternative to the ELISA. Currently, the ELISA is being used to test sera from animals that are imported or exported between PRRSV-infected and PRRSV-free countries. If an ELISA result disagrees with the known immunologic status of an animal, then an alternative serologic test of equal or higher sensitivity should be used to validate the ELISA result. The feasibility of using purified recombinant proteins adopted in the ELISA system has been demonstrated using other disease organisms. The possibility of incorporating PRRSV ORF 5 recombinant protein in the ELISA system is currently being explored.
